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background:  Previously, we demonstrated superior suppression of neointimal proliferation of ciglitazone- eluting stents (CES) in 
comparison to sirolimus- and everolimus-eluting stents and bare metal stents (BMS) in rabbits. We aimed to investigate endothelial 
coverage of the novel CES.
methods:  Non-polymeric CES were produced by coating BMS (2.5 x 12 mm microporous Yukon Choice) with ciglitazone (39 mcg/mm 
stent length). Three New Zealand White rabbits fed with high cholesterol diet underwent stent implantation in both common iliac arteries 
(left: CES, right: Yukon Choice BMS). To assess endothelial maturation, luminal surfaces of the stented arteries were dual stained with 
CD31 and thrombomodulin post-mortem. For each stent strut the coverage of CD31+ endothelial cells was visually estimated (Fig. 
1). Stented arteries were bisected longitudinally. Low power images (SEM) of the luminal surface were acquired and photographed at 
incremental magnifications. Percentage of endothelialisation was evaluated between and above struts (Fig. 2).
results:  7 days after implantation, the CES showed sufficient endothelial coverage above and between stent struts of ~ 85 % in confocal 
microscopic (Table 1) and of 77-87 % in SEM analysis (Table 2). There was no difference regarding strut coverage between CES and BMS.
Conclusion:  The non-polymeric CES proved adequate safety in terms of endothelial coverage in this preclinical model. Taking our 
previous results into account the CES deserves further evaluation.
